Dr. Chatta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Elm and Carlton St
Buffalo, NY 14263Phone+1 716-845-2300Fax+1 716-845-3519
Education & Training
University of WashingtonFellowship, Hematology and Medical Oncology, 1995 - 1996- University of WashingtonFellowship, Geriatric Medicine (Internal Medicine), 1988 - 1992
Aurora Health CareResidency, Internal Medicine, 1986 - 1988
SSM Health/Saint Louis University School of MedicineResidency, Pediatrics, 1985 - 1985
Delhi University College of Medical SciencesClass of 1979
Certifications & Licensure
NY State Medical License 2016 - 2025
WA State Medical License 1988 - 2025
AK State Medical License 2015 - 2024
PA State Medical License 2001 - 2024
AR State Medical License 1997 - 2001
WI State Medical License 1986 - 1989- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification HealthSentry EHR, Cerner Corporation, 2013
Clinical Trials
- Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 1999 Jun 01
- Thalidomide and Doxil® in Patients With Androgen Independent Prostate Cancer (AIPC) Start of enrollment: 2006 Mar 01
- Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer Start of enrollment: 2021 Apr 15
- Join now to see all
Publications & Presentations
PubMed
- 47 citationsFunctional reprogramming of human prostate cancer to promote local attraction of effector CD8(+) T cells.Ravikumar Muthuswamy, John M. Corman, Kathryn Dahl, Gurkamal Chatta, Pawel Kalinski
The Prostate. 2016-09-01 - 229 citationsDouble-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ...Tomasz M. Beer, Christopher W. Ryan, Peter Venner, Daniel P. Petrylak, Gurkamal Chatta
Journal of Clinical Oncology. 2007-02-09 - 92 citationsPharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myelomaDonna E. Reece, Daniel M. Sullivan, Sagar Lonial, Ann Mohrbacher, Gurkamal Chatta
Cancer Chemotherapy and Pharmacology. 2011-01-01
Press Mentions
Does the Common Cold Virus Kill Bladder Cancer?July 24th, 2019
Hemispherx Announces Progress Toward Opening of Prostate Cancer Study at Roswell Park Comprehensive Cancer CenterMay 13th, 2019
Clinical Trial Hopes to Provide Less Toxic Treatment for Prostate CancerOctober 18th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
